2024 Q2 Form 10-K Financial Statement

#000109690624000859 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $568.1K $19.12K $75.13K
YoY Change -4.06% -15.02%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $568.1K $75.13K $75.13K
YoY Change 2323.39% 276.78% -15.02%
Operating Profit -$568.1K -$75.13K
YoY Change 2323.39% -15.02%
Interest Expense $32.11K $122.4K -$122.4K
YoY Change 5.42% -507.15% -203.89%
% of Operating Profit
Other Income/Expense, Net -$32.11K -$397.4K
YoY Change 5.42% 100.48%
Pretax Income -$600.2K -$472.5K -$472.5K
YoY Change 1013.67% 262.39% 64.85%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$600.2K -$472.5K -$472.5K
YoY Change 1013.67% 262.39% 64.85%
Net Earnings / Revenue
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.08 -$0.04 -$0.06
COMMON SHARES
Basic Shares Outstanding 7.498M shares 7.498M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.370K $490.00 $490.00
YoY Change -30.99% -30.99%
Cash & Equivalents $1.367K $493.00 $490.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.367K $493.00 $490.00
YoY Change 1109.73% -30.27% -30.99%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $1.367K $493.00 $490.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.367K $493.00 $490.00
YoY Change -99.5% -99.82% -99.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $237.4K $207.8K $217.3K
YoY Change 21.94% 16.46% 15.02%
Accrued Expenses $394.9K $351.3K $516.1K
YoY Change 18.84% 21.07% 23.52%
Deferred Revenue
YoY Change
Short-Term Debt $746.9K $701.7K $701.7K
YoY Change 7.06% 7.06%
Long-Term Debt Due $346.9K $326.7K
YoY Change
Total Short-Term Liabilities $1.553M $1.435M $1.435M
YoY Change 13.69% 13.7% 13.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.553M $1.435M $1.435M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.553M $1.435M $1.435M
YoY Change 13.69% 13.7% 13.7%
SHAREHOLDERS EQUITY
Retained Earnings -$3.080M -$2.429M
YoY Change 49.49% 24.15%
Common Stock $7.498K $7.498K
YoY Change 1.86% 1.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.551M -$1.435M -$1.435M
YoY Change
Total Liabilities & Shareholders Equity $1.367K $493.00 $490.00
YoY Change -99.5% -99.82% -99.82%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$600.2K -$472.5K -$472.5K
YoY Change 1013.67% 262.39% 64.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$13.31K -$33.21K -$70.89K
YoY Change 557.62% 82.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.67K 33.32K $46.30K
YoY Change 566.4% 17.36%
NET CHANGE
Cash From Operating Activities -13.31K -33.21K -$70.89K
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 12.67K 33.32K $46.30K
Net Change In Cash -640.0 110.0 -$24.59K
YoY Change -320.0% -4818.81%
FREE CASH FLOW
Cash From Operating Activities -$13.31K -$33.21K -$70.89K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Entity File Number
EntityFileNumber
333-151300
CY2023 dei Entity Registrant Name
EntityRegistrantName
SPIRITS TIME INTERNATIONAL, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3455830
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1661 Lakeview Circle
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Ogden
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84403
CY2023 dei Country Region
CountryRegion
801
CY2023 dei City Area Code
CityAreaCode
399
CY2023 dei Local Phone Number
LocalPhoneNumber
3632
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
702812 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7498305 shares
CY2023 dei Auditor Firm
AuditorFirmId
318
CY2023 dei Auditor Name
AuditorName
L J Soldinger Associates, LLC
CY2023 dei Auditor Location
AuditorLocation
Deer Park, IL
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
493 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
707 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
493 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
707 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
275000 usd
CY2023Q4 us-gaap Assets
Assets
493 usd
CY2022Q4 us-gaap Assets
Assets
275707 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
207775 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
178409 usd
CY2023Q4 fil Accounts Payable Related Party
AccountsPayableRelatedParty
9500 usd
CY2022Q4 fil Accounts Payable Related Party
AccountsPayableRelatedParty
10500 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
351285 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
290153 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
164819 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
127684 usd
CY2023Q4 fil Loans Payable Related Parties
LoansPayableRelatedParties
271675 usd
CY2022Q4 fil Loans Payable Related Parties
LoansPayableRelatedParties
235375 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290000 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
85000 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
75000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1435054 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1262121 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1435054 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1262121 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7498305 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7498305 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7361005 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7361005 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7498 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7361 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
986354 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
962120 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2428868 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1956350 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1434561 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-986414 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
493 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
275707 usd
CY2023Q4 us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap Revenues
Revenues
0 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
63136 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
78337 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11994 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10077 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
75130 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
88414 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-75130 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-88414 usd
CY2023Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2022Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
80404 usd
CY2023Q4 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
275000 usd
CY2022Q4 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
122388 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
117810 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-397388 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-198214 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-472518 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-286628 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-472518 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-286628 usd
CY2023Q4 fil Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.06
CY2022Q4 fil Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.04
CY2023Q4 fil Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7394107 shares
CY2022Q4 fil Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
7361005 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-720306 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20520 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-286628 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-986414 usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
24371 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-472518 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1434561 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-472518 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-286628 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
20520 usd
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
80404 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
275000 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90498 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
121184 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-1000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1000 usd
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-37135 usd
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-24591 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70885 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38929 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
20000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
36300 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19450 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46300 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39450 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-214 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
521 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
707 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
707 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
9000 usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
24371 usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
264084 shares
CY2023 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
7974315 shares
CY2022 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
1194633 shares
CY2023 us-gaap Profit Loss
ProfitLoss
-472518 usd
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7498305 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022 us-gaap Profit Loss
ProfitLoss
-286628 usd
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7361005 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;margin-left:18pt;text-align:justify">Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:10pt Times New Roman;margin:0;margin-left:18pt;text-align:justify">Concentration of Risk - Cash - The Company at times may maintain a cash balance in excess of insured limits. At December 31, 2023 and 2022, the Company has no cash in excess of insured limits.</p>
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
80404 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
275000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
275000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
505000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
406000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
505000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
406000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
99000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
62000 usd
CY2023 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
0 usd
CY2022 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
4000 usd
CY2023 fil Change In Valuation Allowance
ChangeInValuationAllowance
-99000 usd
CY2022 fil Change In Valuation Allowance
ChangeInValuationAllowance
-58000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
36300 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19450 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
9000 usd
CY2023Q4 fil Accounts Payable Related Party
AccountsPayableRelatedParty
9500 usd
CY2022Q4 fil Accounts Payable Related Party
AccountsPayableRelatedParty
10500 usd
CY2022Q3 fil Preferred Series A Stock To Directors Of The Company
PreferredSeriesAStockToDirectorsOfTheCompany
300000 shares
CY2022Q3 fil Preferred Series A Stock To An Unaffiliated Individual
PreferredSeriesAStockToAnUnaffiliatedIndividual
50000 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
493 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
707 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
275000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
24121 usd
CY2023 fil Conversion Fees
ConversionFees
250 usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
24371 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
85000 usd
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
75000 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
85000 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
75000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7498305 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7498305 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7361005 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7361005 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20520 usd

Files In Submission

Name View Source Status
0001096906-24-000859-index-headers.html Edgar Link pending
0001096906-24-000859-index.html Edgar Link pending
0001096906-24-000859.txt Edgar Link pending
0001096906-24-000859-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srgs_ex31z1.htm Edgar Link pending
srgs_ex32z1.htm Edgar Link pending
srsg-20231231.htm Edgar Link pending
srsg-20231231.xsd Edgar Link pending
srsg-20231231_def.xml Edgar Link unprocessable
srsg-20231231_lab.xml Edgar Link unprocessable
srsg-20231231_pre.xml Edgar Link unprocessable
srsg-20231231_htm.xml Edgar Link completed
srsg-20231231_cal.xml Edgar Link unprocessable